XML 15 R2.htm IDEA: XBRL DOCUMENT
v3.25.1

Pay vs Performance Disclosure - USD ($) | 12 Months Ended
--- | ---
Dec. 31, 2024 | Dec. 31, 2023 | Dec. 31, 2022
Pay vs Performance Disclosure |  |  |
Pay vs Performance Disclosure, Table | Pay versus Performance Table
(a) | ​ | ​ | (b) | ​ | ​ | (c) | ​ | ​ | (d) | ​ | ​ | (e) | ​ | ​ | (f) | ​ | ​ | (g) | ​ | ​ | (h) | ​ | ​ | (i) | ​
Year(1) | ​ | ​ | Summary Compensation Table Total for Principal Executive Officer (“PEO”) 1(2) ($) | ​ | ​ | Compensation Actually Paid to PEO 1(3) ($) | ​ | ​ | Summary Compensation Table Total for PEO 2(2) ($) | ​ | ​ | Compensation Actually Paid to PEO 2(3) ($) | ​ | ​ | Average Summary Compensation Table Total for Non-PEO Named Executive Officers (“NEOs”)(4) ($) | ​ | ​ | Average Compensation Actually Paid to Non-PEO NEOs(5) ($) | ​ | ​ | Value of Initial Fixed $100 Investment Based on Total Shareholder Return (“TSR”)(6) ($) | ​ | ​ | Net Income(7) (Thousands) ($) | ​
2024 | ​ | ​ | ​ | ​ | 1,584,176 | ​ | ​ | ​ | ​ | ​ | 745,181 | ​ | ​ | ​ | ​ | ​ | — | ​ | ​ | ​ | ​ | ​ | — | ​ | ​ | ​ | ​ | ​ | 576,350 | ​ | ​ | ​ | ​ | ​ | 433,200 | ​ | ​ | ​ | ​ | ​ | 33 | ​ | ​ | ​ | ​ | ​ | (18,916) | ​ | ​
2023 | ​ | ​ | ​ | ​ | 1,133,931 | ​ | ​ | ​ | ​ | ​ | 1,421,104 | ​ | ​ | ​ | ​ | ​ | 634,140 | ​ | ​ | ​ | ​ | ​ | 578,496 | ​ | ​ | ​ | ​ | ​ | 316,267 | ​ | ​ | ​ | ​ | ​ | 357,361 | ​ | ​ | ​ | ​ | ​ | 58 | ​ | ​ | ​ | ​ | ​ | (69,045) | ​ | ​
2022 | ​ | ​ | ​ | ​ | 1,639,908 | ​ | ​ | ​ | ​ | ​ | (347,905) | ​ | ​ | ​ | ​ | ​ | — | ​ | ​ | ​ | ​ | ​ | — | ​ | ​ | ​ | ​ | ​ | 586,033 | ​ | ​ | ​ | ​ | ​ | 278,524 | ​ | ​ | ​ | ​ | ​ | 22 | ​ | ​ | ​ | ​ | ​ | (36,917) | ​ | ​
​ (1) We are a smaller reporting company pursuant to Rule 405 of the Securities Act of 1933, and as such, we are only required to include information for the past three fiscal years in this table. ​ (2) The dollar amounts reported in column (b) for the fiscal year 2024 is the amount of total compensation reported for Dr. Birx (“PEO 1”). The dollar amounts reported in columns (b) and (d) for the fiscal year 2023 is the amounts of total compensation reported for Dr. Birx (our Chief Executive Officer since July 10, 2023) (“PEO 1”) and Dr. Varnum (our Chief Executive Officer until July 10, 2023) (“PEO 2”), respectively. The dollar amounts reported in columns (b) and (d) for the fiscal year 2022 are the amount of total compensation reported for Dr. Varnum (our Chief Executive Officer until July 10, 2023) (“PEO 1”). Refer to “Executive Compensation - Summary Compensation Table” above. ​ (3) The dollar amounts reported in columns (c) and (e) represent the amount of “compensation actually paid” to Dr. Birx and Dr. Varnum, respectively, as computed in accordance with Item 402(v) of Regulation S-K. The dollar amounts do not reflect the actual amount of compensation earned by or paid to Dr. Birx and Dr. Varnum during the applicable year. In accordance with the requirements of Item 402(v) of Regulation S-K, the adjustments made to Dr. Birx’s and Dr. Varnum’s total compensation for each year to determine the compensation actually paid are shown in the “Adjustments to Compensation Actually Paid” table below. ​ (4) The dollar amounts reported in column (f) represent the average of the amounts reported for our Company’s named executive officers (other than Dr. Birx and Dr. Varnum) as a group (“NEOs”) in the “Total” column of the Summary Compensation Table in each applicable year. The names of each of the NEOs included for purposes of calculating the average amounts in each applicable year are as follows: (i) for 2024, Pierre Kyme, David House, Mina Pastagia, and Richard Rychlik; and (ii) for 2023, Richard Rychlik, Mina Pastagia and Erin Butler; (iii) for 2022, Mina Pastagia, Erin Butler and Steve Martin. (5) The dollar amounts reported in column (g) represent the average amount of “compensation actually paid” to the NEOs as a group, as computed in accordance with Item 402(v) of Regulation S-K. The dollar amounts do not reflect the actual average amount of compensation earned by or paid to the NEOs as a group during the applicable year. In accordance with the requirements of Item 402(v) of Regulation S-K, the adjustments made to the average total compensation for the NEOs as a group for each year to determine the average compensation actually paid are shown in the “Adjustments to Compensation Actually Paid” table below. ​ (6) Cumulative total shareholder return (“TSR”) is calculated by dividing the sum of the cumulative amount of dividends for the measurement period, assuming dividend reinvestment, and the difference between our Company’s share price at the end and the beginning of the measurement period (December 31, 2021) by our Company’s share price at the beginning of the measurement period. No dividends were paid on stock or option awards in 2022, 2023 or 2024. ​ (7) The dollar amounts reported represent the amount of net income (loss) reflected in our audited financial statements for the applicable covered year. ​ Adjustments to Compensation Actually Paid As noted above in footnotes 3 and 5 to the Pay versus Performance Table, in accordance with the requirements of Item 402(v) of Regulation S-K, the following adjustments were made to (i) Dr. Birx and Dr. Varnum’s total compensation for each year, as applicable, to determine the compensation actually paid to each of them, and (ii) to the average total compensation for the NEOs as a group for each year to determine the average compensation actually paid to them. The methodology used to determine compensation actually paid is further described in footnotes (a), (b) and (c) below.
​ | ​ | ​ | FY 2022 | ​
Adjustments: | ​ | ​ | PEO Varnum | ​ | ​ | Other NEOs Average(c) | ​
Total from Summary Compensation Table | ​ | ​ | ​ | $ | 1,639,908 | ​ | ​ | ​ | ​ | $ | 586,033 | ​ | ​
Adjustments for stock and options awards | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
Deduct: SCT Amounts(a) | ​ | ​ | ​ | ​ | (904,908) | ​ | ​ | ​ | ​ | ​ | (163,386) | ​ | ​
Add: Fair value of equity granted during fiscal year, outstanding and unvested as of end of fiscal year﻿(b) | ​ | ​ | ​ | ​ | 297,600 | ​ | ​ | ​ | ​ | ​ | 53,733 | ​ | ​
Add (Deduct): Change in fair value of equity granted in prior year that is outstanding and unvested at the end of fiscal year﻿(b) | ​ | ​ | ​ | ​ | (1,194,828) | ​ | ​ | ​ | ​ | ​ | (156,767) | ​ | ​
Add (Deduct): Change in fair value for awards granted in prior fiscal years that vested in fiscal year | ​ | ​ | ​ | ​ | (185,677) | ​ | ​ | ​ | ​ | ​ | (41,089) | ​ | ​
Total adjustments for stock and option awards | ​ | ​ | ​ | ​ | (1,987,813) | ​ | ​ | ​ | ​ | ​ | (307,508) | ​ | ​
Compensation Actually Paid (as calculated) | ​ | ​ | ​ | $ | (347,905) | ​ | ​ | ​ | ​ | $ | 278,524 | ​ | ​
​ | ​ | ​ | FY 2023 | ​
Adjustments: | ​ | ​ | PEO Birx | ​ | ​ | PEO Varnum | ​ | ​ | Other NEOs Average(c) | ​
Total from Summary Compensation Table | ​ | ​ | ​ | $ | 1,133,931 | ​ | ​ | ​ | ​ | $ | 634,140 | ​ | ​ | ​ | ​ | $ | 316,267 | ​ | ​
Adjustments for stock and options awards | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
Deduct: SCT Amounts(a) | ​ | ​ | ​ | ​ | (875,477) | ​ | ​ | ​ | ​ | ​ | — | ​ | ​ | ​ | ​ | ​ | (33,087) | ​ | ​
Add: Fair value of equity granted during fiscal year, outstanding and unvested as of end of fiscal year﻿(b) | ​ | ​ | ​ | ​ | 1,162,650 | ​ | ​ | ​ | ​ | ​ | — | ​ | ​ | ​ | ​ | ​ | 43,032 | ​ | ​
Add (Deduct): Change in fair value of equity granted in prior year that is outstanding and unvested at the end of fiscal year﻿(b) | ​ | ​ | ​ | ​ | — | ​ | ​ | ​ | ​ | ​ | 5,713 | ​ | ​ | ​ | ​ | ​ | 36,606 | ​ | ​
Add (Deduct): Change in fair value for awards granted in prior fiscal years that vested in fiscal year﻿(b) | ​ | ​ | ​ | ​ | — | ​ | ​ | ​ | ​ | ​ | 60,616 | ​ | ​ | ​ | ​ | ​ | 10,772 | ​ | ​
(Deduct): The amount of fair value at the end of prior year for awards granted in prior years that forfeited during the fiscal year | ​ | ​ | ​ | ​ | — | ​ | ​ | ​ | ​ | ​ | (121,973) | ​ | ​ | ​ | ​ | ​ | (16,229) | ​ | ​
Total adjustments for stock and option awards | ​ | ​ | ​ | ​ | 287,173 | ​ | ​ | ​ | ​ | ​ | (55,644) | ​ | ​ | ​ | ​ | ​ | 41,094 | ​ | ​
Compensation Actually Paid (as calculated) | ​ | ​ | ​ | $ | 1,421,104 | ​ | ​ | ​ | ​ | $ | 578,496 | ​ | ​ | ​ | ​ | $ | 357,361 | ​ | ​
​ | ​ | ​ | FY 2024 | ​
Adjustments: | ​ | ​ | PEO Birx | ​ | ​ | Other NEOs Average(b) | ​
Total from Summary Compensation Table | ​ | ​ | ​ | $ | 1,584,176 | ​ | ​ | ​ | ​ | $ | 576,350 | ​ | ​
Adjustments for stock and options awards | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
Deduct: SCT Amounts(a) | ​ | ​ | ​ | ​ | (828,248) | ​ | ​ | ​ | ​ | ​ | (137,225) | ​ | ​
Add: Fair value of equity granted during fiscal year, outstanding and unvested as of end of fiscal year﻿(b) | ​ | ​ | ​ | ​ | 430,358 | ​ | ​ | ​ | ​ | ​ | 45,033 | ​ | ​
Add (Deduct): Change in fair value of equity granted in prior year that is outstanding and unvested at the end of fiscal year﻿(b) | ​ | ​ | ​ | ​ | (386,807) | ​ | ​ | ​ | ​ | ​ | (7,275) | ​ | ​
Add (Deduct): Change in fair value for awards granted in prior fiscal years that vested in fiscal year | ​ | ​ | ​ | ​ | (54,299) | ​ | ​ | ​ | ​ | ​ | 4,366 | ​ | ​
(Deduct): The amount of fair value at the end of prior year for awards granted in prior years that forfeited during the fiscal year | ​ | ​ | ​ | ​ | — | ​ | ​ | ​ | ​ | ​ | (48,049) | ​ | ​
Total adjustments for stock and option awards | ​ | ​ | ​ | ​ | (838,996) | ​ | ​ | ​ | ​ | ​ | (143,150) | ​ | ​
Compensation Actually Paid (as calculated) | ​ | ​ | ​ | $ | 745,181 | ​ | ​ | ​ | ​ | $ | 433,200 | ​ | ​
​ (a) The grant date fair value of equity awards represents the sum of the totals of the amounts reported in the “Stock Awards” and/or “Option Awards” columns, as applicable, in the Summary Compensation Table for the applicable year. ​ (b) The equity award adjustments for each applicable year include the addition (or subtraction, as applicable) of the following, to the extent applicable: (i) the year-end fair value of any equity awards granted in the applicable year that are outstanding and unvested as of the end of the year; (ii) the amount of change as of the end of the applicable year (from the end of the prior fiscal year) in fair value of any awards granted in prior years that are outstanding and unvested as of the end of the applicable year; (iii) for awards that are granted and vest in same applicable year, the fair value as of the vesting date; (iv) for awards granted in prior years that vest in the applicable year, the amount equal to the change as of the vesting date (from the end of the prior fiscal year) in fair value; (v) for awards granted in prior years that are determined to fail to meet the applicable vesting conditions during the applicable year, a deduction for the amount equal to the fair value at the end of the prior fiscal year; and (vi) the dollar value of any dividends or other earnings paid on stock or option awards in the applicable year prior to the vesting date that are not otherwise reflected in the fair value of such award or included in any other component of total compensation for the applicable year. ​ (c) For the NEOs as a group in each applicable year, all amounts shown represent averages. |  |
Named Executive Officers, Footnote | (2) The dollar amounts reported in column (b) for the fiscal year 2024 is the amount of total compensation reported for Dr. Birx (“PEO 1”). The dollar amounts reported in columns (b) and (d) for the fiscal year 2023 is the amounts of total compensation reported for Dr. Birx (our Chief Executive Officer since July 10, 2023) (“PEO 1”) and Dr. Varnum (our Chief Executive Officer until July 10, 2023) (“PEO 2”), respectively. The dollar amounts reported in columns (b) and (d) for the fiscal year 2022 are the amount of total compensation reported for Dr. Varnum (our Chief Executive Officer until July 10, 2023) (“PEO 1”). Refer to “Executive Compensation - Summary Compensation Table” above. (4) The dollar amounts reported in column (f) represent the average of the amounts reported for our Company’s named executive officers (other than Dr. Birx and Dr. Varnum) as a group (“NEOs”) in the “Total” column of the Summary Compensation Table in each applicable year. The names of each of the NEOs included for purposes of calculating the average amounts in each applicable year are as follows: (i) for 2024, Pierre Kyme, David House, Mina Pastagia, and Richard Rychlik; and (ii) for 2023, Richard Rychlik, Mina Pastagia and Erin Butler; (iii) for 2022, Mina Pastagia, Erin Butler and Steve Martin. |  |
Adjustment To PEO Compensation, Footnote |
​ | ​ | ​ | FY 2022 | ​
Adjustments: | ​ | ​ | PEO Varnum | ​ | ​ | Other NEOs Average(c) | ​
Total from Summary Compensation Table | ​ | ​ | ​ | $ | 1,639,908 | ​ | ​ | ​ | ​ | $ | 586,033 | ​ | ​
Adjustments for stock and options awards | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
Deduct: SCT Amounts(a) | ​ | ​ | ​ | ​ | (904,908) | ​ | ​ | ​ | ​ | ​ | (163,386) | ​ | ​
Add: Fair value of equity granted during fiscal year, outstanding and unvested as of end of fiscal year﻿(b) | ​ | ​ | ​ | ​ | 297,600 | ​ | ​ | ​ | ​ | ​ | 53,733 | ​ | ​
Add (Deduct): Change in fair value of equity granted in prior year that is outstanding and unvested at the end of fiscal year﻿(b) | ​ | ​ | ​ | ​ | (1,194,828) | ​ | ​ | ​ | ​ | ​ | (156,767) | ​ | ​
Add (Deduct): Change in fair value for awards granted in prior fiscal years that vested in fiscal year | ​ | ​ | ​ | ​ | (185,677) | ​ | ​ | ​ | ​ | ​ | (41,089) | ​ | ​
Total adjustments for stock and option awards | ​ | ​ | ​ | ​ | (1,987,813) | ​ | ​ | ​ | ​ | ​ | (307,508) | ​ | ​
Compensation Actually Paid (as calculated) | ​ | ​ | ​ | $ | (347,905) | ​ | ​ | ​ | ​ | $ | 278,524 | ​ | ​
​ | ​ | ​ | FY 2023 | ​
Adjustments: | ​ | ​ | PEO Birx | ​ | ​ | PEO Varnum | ​ | ​ | Other NEOs Average(c) | ​
Total from Summary Compensation Table | ​ | ​ | ​ | $ | 1,133,931 | ​ | ​ | ​ | ​ | $ | 634,140 | ​ | ​ | ​ | ​ | $ | 316,267 | ​ | ​
Adjustments for stock and options awards | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
Deduct: SCT Amounts(a) | ​ | ​ | ​ | ​ | (875,477) | ​ | ​ | ​ | ​ | ​ | — | ​ | ​ | ​ | ​ | ​ | (33,087) | ​ | ​
Add: Fair value of equity granted during fiscal year, outstanding and unvested as of end of fiscal year﻿(b) | ​ | ​ | ​ | ​ | 1,162,650 | ​ | ​ | ​ | ​ | ​ | — | ​ | ​ | ​ | ​ | ​ | 43,032 | ​ | ​
Add (Deduct): Change in fair value of equity granted in prior year that is outstanding and unvested at the end of fiscal year﻿(b) | ​ | ​ | ​ | ​ | — | ​ | ​ | ​ | ​ | ​ | 5,713 | ​ | ​ | ​ | ​ | ​ | 36,606 | ​ | ​
Add (Deduct): Change in fair value for awards granted in prior fiscal years that vested in fiscal year﻿(b) | ​ | ​ | ​ | ​ | — | ​ | ​ | ​ | ​ | ​ | 60,616 | ​ | ​ | ​ | ​ | ​ | 10,772 | ​ | ​
(Deduct): The amount of fair value at the end of prior year for awards granted in prior years that forfeited during the fiscal year | ​ | ​ | ​ | ​ | — | ​ | ​ | ​ | ​ | ​ | (121,973) | ​ | ​ | ​ | ​ | ​ | (16,229) | ​ | ​
Total adjustments for stock and option awards | ​ | ​ | ​ | ​ | 287,173 | ​ | ​ | ​ | ​ | ​ | (55,644) | ​ | ​ | ​ | ​ | ​ | 41,094 | ​ | ​
Compensation Actually Paid (as calculated) | ​ | ​ | ​ | $ | 1,421,104 | ​ | ​ | ​ | ​ | $ | 578,496 | ​ | ​ | ​ | ​ | $ | 357,361 | ​ | ​
​ | ​ | ​ | FY 2024 | ​
Adjustments: | ​ | ​ | PEO Birx | ​ | ​ | Other NEOs Average(b) | ​
Total from Summary Compensation Table | ​ | ​ | ​ | $ | 1,584,176 | ​ | ​ | ​ | ​ | $ | 576,350 | ​ | ​
Adjustments for stock and options awards | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
Deduct: SCT Amounts(a) | ​ | ​ | ​ | ​ | (828,248) | ​ | ​ | ​ | ​ | ​ | (137,225) | ​ | ​
Add: Fair value of equity granted during fiscal year, outstanding and unvested as of end of fiscal year﻿(b) | ​ | ​ | ​ | ​ | 430,358 | ​ | ​ | ​ | ​ | ​ | 45,033 | ​ | ​
Add (Deduct): Change in fair value of equity granted in prior year that is outstanding and unvested at the end of fiscal year﻿(b) | ​ | ​ | ​ | ​ | (386,807) | ​ | ​ | ​ | ​ | ​ | (7,275) | ​ | ​
Add (Deduct): Change in fair value for awards granted in prior fiscal years that vested in fiscal year | ​ | ​ | ​ | ​ | (54,299) | ​ | ​ | ​ | ​ | ​ | 4,366 | ​ | ​
(Deduct): The amount of fair value at the end of prior year for awards granted in prior years that forfeited during the fiscal year | ​ | ​ | ​ | ​ | — | ​ | ​ | ​ | ​ | ​ | (48,049) | ​ | ​
Total adjustments for stock and option awards | ​ | ​ | ​ | ​ | (838,996) | ​ | ​ | ​ | ​ | ​ | (143,150) | ​ | ​
Compensation Actually Paid (as calculated) | ​ | ​ | ​ | $ | 745,181 | ​ | ​ | ​ | ​ | $ | 433,200 | ​ | ​
​ (a) The grant date fair value of equity awards represents the sum of the totals of the amounts reported in the “Stock Awards” and/or “Option Awards” columns, as applicable, in the Summary Compensation Table for the applicable year. ​ (b) The equity award adjustments for each applicable year include the addition (or subtraction, as applicable) of the following, to the extent applicable: (i) the year-end fair value of any equity awards granted in the applicable year that are outstanding and unvested as of the end of the year; (ii) the amount of change as of the end of the applicable year (from the end of the prior fiscal year) in fair value of any awards granted in prior years that are outstanding and unvested as of the end of the applicable year; (iii) for awards that are granted and vest in same applicable year, the fair value as of the vesting date; (iv) for awards granted in prior years that vest in the applicable year, the amount equal to the change as of the vesting date (from the end of the prior fiscal year) in fair value; (v) for awards granted in prior years that are determined to fail to meet the applicable vesting conditions during the applicable year, a deduction for the amount equal to the fair value at the end of the prior fiscal year; and (vi) the dollar value of any dividends or other earnings paid on stock or option awards in the applicable year prior to the vesting date that are not otherwise reflected in the fair value of such award or included in any other component of total compensation for the applicable year. ​ (c) For the NEOs as a group in each applicable year, all amounts shown represent averages. |  |
Non-PEO NEO Average Total Compensation Amount | $ 576,350 | $ 316,267 | $ 586,033
Non-PEO NEO Average Compensation Actually Paid Amount | $ 433,200 | 357,361 | 278,524
Adjustment to Non-PEO NEO Compensation Footnote |
​ | ​ | ​ | FY 2022 | ​
Adjustments: | ​ | ​ | PEO Varnum | ​ | ​ | Other NEOs Average(c) | ​
Total from Summary Compensation Table | ​ | ​ | ​ | $ | 1,639,908 | ​ | ​ | ​ | ​ | $ | 586,033 | ​ | ​
Adjustments for stock and options awards | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
Deduct: SCT Amounts(a) | ​ | ​ | ​ | ​ | (904,908) | ​ | ​ | ​ | ​ | ​ | (163,386) | ​ | ​
Add: Fair value of equity granted during fiscal year, outstanding and unvested as of end of fiscal year﻿(b) | ​ | ​ | ​ | ​ | 297,600 | ​ | ​ | ​ | ​ | ​ | 53,733 | ​ | ​
Add (Deduct): Change in fair value of equity granted in prior year that is outstanding and unvested at the end of fiscal year﻿(b) | ​ | ​ | ​ | ​ | (1,194,828) | ​ | ​ | ​ | ​ | ​ | (156,767) | ​ | ​
Add (Deduct): Change in fair value for awards granted in prior fiscal years that vested in fiscal year | ​ | ​ | ​ | ​ | (185,677) | ​ | ​ | ​ | ​ | ​ | (41,089) | ​ | ​
Total adjustments for stock and option awards | ​ | ​ | ​ | ​ | (1,987,813) | ​ | ​ | ​ | ​ | ​ | (307,508) | ​ | ​
Compensation Actually Paid (as calculated) | ​ | ​ | ​ | $ | (347,905) | ​ | ​ | ​ | ​ | $ | 278,524 | ​ | ​
​ | ​ | ​ | FY 2023 | ​
Adjustments: | ​ | ​ | PEO Birx | ​ | ​ | PEO Varnum | ​ | ​ | Other NEOs Average(c) | ​
Total from Summary Compensation Table | ​ | ​ | ​ | $ | 1,133,931 | ​ | ​ | ​ | ​ | $ | 634,140 | ​ | ​ | ​ | ​ | $ | 316,267 | ​ | ​
Adjustments for stock and options awards | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
Deduct: SCT Amounts(a) | ​ | ​ | ​ | ​ | (875,477) | ​ | ​ | ​ | ​ | ​ | — | ​ | ​ | ​ | ​ | ​ | (33,087) | ​ | ​
Add: Fair value of equity granted during fiscal year, outstanding and unvested as of end of fiscal year﻿(b) | ​ | ​ | ​ | ​ | 1,162,650 | ​ | ​ | ​ | ​ | ​ | — | ​ | ​ | ​ | ​ | ​ | 43,032 | ​ | ​
Add (Deduct): Change in fair value of equity granted in prior year that is outstanding and unvested at the end of fiscal year﻿(b) | ​ | ​ | ​ | ​ | — | ​ | ​ | ​ | ​ | ​ | 5,713 | ​ | ​ | ​ | ​ | ​ | 36,606 | ​ | ​
Add (Deduct): Change in fair value for awards granted in prior fiscal years that vested in fiscal year﻿(b) | ​ | ​ | ​ | ​ | — | ​ | ​ | ​ | ​ | ​ | 60,616 | ​ | ​ | ​ | ​ | ​ | 10,772 | ​ | ​
(Deduct): The amount of fair value at the end of prior year for awards granted in prior years that forfeited during the fiscal year | ​ | ​ | ​ | ​ | — | ​ | ​ | ​ | ​ | ​ | (121,973) | ​ | ​ | ​ | ​ | ​ | (16,229) | ​ | ​
Total adjustments for stock and option awards | ​ | ​ | ​ | ​ | 287,173 | ​ | ​ | ​ | ​ | ​ | (55,644) | ​ | ​ | ​ | ​ | ​ | 41,094 | ​ | ​
Compensation Actually Paid (as calculated) | ​ | ​ | ​ | $ | 1,421,104 | ​ | ​ | ​ | ​ | $ | 578,496 | ​ | ​ | ​ | ​ | $ | 357,361 | ​ | ​
​ | ​ | ​ | FY 2024 | ​
Adjustments: | ​ | ​ | PEO Birx | ​ | ​ | Other NEOs Average(b) | ​
Total from Summary Compensation Table | ​ | ​ | ​ | $ | 1,584,176 | ​ | ​ | ​ | ​ | $ | 576,350 | ​ | ​
Adjustments for stock and options awards | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
Deduct: SCT Amounts(a) | ​ | ​ | ​ | ​ | (828,248) | ​ | ​ | ​ | ​ | ​ | (137,225) | ​ | ​
Add: Fair value of equity granted during fiscal year, outstanding and unvested as of end of fiscal year﻿(b) | ​ | ​ | ​ | ​ | 430,358 | ​ | ​ | ​ | ​ | ​ | 45,033 | ​ | ​
Add (Deduct): Change in fair value of equity granted in prior year that is outstanding and unvested at the end of fiscal year﻿(b) | ​ | ​ | ​ | ​ | (386,807) | ​ | ​ | ​ | ​ | ​ | (7,275) | ​ | ​
Add (Deduct): Change in fair value for awards granted in prior fiscal years that vested in fiscal year | ​ | ​ | ​ | ​ | (54,299) | ​ | ​ | ​ | ​ | ​ | 4,366 | ​ | ​
(Deduct): The amount of fair value at the end of prior year for awards granted in prior years that forfeited during the fiscal year | ​ | ​ | ​ | ​ | — | ​ | ​ | ​ | ​ | ​ | (48,049) | ​ | ​
Total adjustments for stock and option awards | ​ | ​ | ​ | ​ | (838,996) | ​ | ​ | ​ | ​ | ​ | (143,150) | ​ | ​
Compensation Actually Paid (as calculated) | ​ | ​ | ​ | $ | 745,181 | ​ | ​ | ​ | ​ | $ | 433,200 | ​ | ​
​ (a) The grant date fair value of equity awards represents the sum of the totals of the amounts reported in the “Stock Awards” and/or “Option Awards” columns, as applicable, in the Summary Compensation Table for the applicable year. ​ (b) The equity award adjustments for each applicable year include the addition (or subtraction, as applicable) of the following, to the extent applicable: (i) the year-end fair value of any equity awards granted in the applicable year that are outstanding and unvested as of the end of the year; (ii) the amount of change as of the end of the applicable year (from the end of the prior fiscal year) in fair value of any awards granted in prior years that are outstanding and unvested as of the end of the applicable year; (iii) for awards that are granted and vest in same applicable year, the fair value as of the vesting date; (iv) for awards granted in prior years that vest in the applicable year, the amount equal to the change as of the vesting date (from the end of the prior fiscal year) in fair value; (v) for awards granted in prior years that are determined to fail to meet the applicable vesting conditions during the applicable year, a deduction for the amount equal to the fair value at the end of the prior fiscal year; and (vi) the dollar value of any dividends or other earnings paid on stock or option awards in the applicable year prior to the vesting date that are not otherwise reflected in the fair value of such award or included in any other component of total compensation for the applicable year. ​ (c) For the NEOs as a group in each applicable year, all amounts shown represent averages. |  |
Compensation Actually Paid vs. Total Shareholder Return |  |  |
Compensation Actually Paid vs. Net Income |  |  |
Total Shareholder Return Amount | $ 33 | 58 | 22
Net Income (Loss) | $ (18,916,000) | (69,045,000) | (36,917,000)
PEO Name | Dr. Birx |  |
Dr. Birx [Member] |  |  |
Pay vs Performance Disclosure |  |  |
PEO Total Compensation Amount | $ 1,584,176 | 1,133,931 |
PEO Actually Paid Compensation Amount | 745,181 | 1,421,104 |
Dr. Varnum [Member] |  |  |
Pay vs Performance Disclosure |  |  |
PEO Total Compensation Amount |  | 634,140 | 1,639,908
PEO Actually Paid Compensation Amount |  | 578,496 | (347,905)
PEO | Dr. Birx [Member] | Equity Awards Adjustments |  |  |
Pay vs Performance Disclosure |  |  |
Adjustment to Compensation, Amount | (838,996) | 287,173 |
PEO | Dr. Birx [Member] | Aggregate Grant Date Fair Value of Equity Award Amounts Reported in Summary Compensation Table |  |  |
Pay vs Performance Disclosure |  |  |
Adjustment to Compensation, Amount | (828,248) | (875,477) |
PEO | Dr. Birx [Member] | Year-end Fair Value of Equity Awards Granted in Covered Year that are Outstanding and Unvested |  |  |
Pay vs Performance Disclosure |  |  |
Adjustment to Compensation, Amount | 430,358 | 1,162,650 |
PEO | Dr. Birx [Member] | Year-over-Year Change in Fair Value of Equity Awards Granted in Prior Years That are Outstanding and Unvested |  |  |
Pay vs Performance Disclosure |  |  |
Adjustment to Compensation, Amount | (386,807) |  |
PEO | Dr. Birx [Member] | Change in Fair Value as of Vesting Date of Prior Year Equity Awards Vested in Covered Year |  |  |
Pay vs Performance Disclosure |  |  |
Adjustment to Compensation, Amount | (54,299) |  |
PEO | Dr. Birx [Member] | Equity Awards Adjustments Change In Fair Value Of Awards Granted In Prior Years Forfeited During Current Year [Member] |  |  |
Pay vs Performance Disclosure |  |  |
Adjustment to Compensation, Amount |  |  |
PEO | Dr. Varnum [Member] | Equity Awards Adjustments |  |  |
Pay vs Performance Disclosure |  |  |
Adjustment to Compensation, Amount |  | (55,644) | (1,987,813)
PEO | Dr. Varnum [Member] | Aggregate Grant Date Fair Value of Equity Award Amounts Reported in Summary Compensation Table |  |  |
Pay vs Performance Disclosure |  |  |
Adjustment to Compensation, Amount |  |  | (904,908)
PEO | Dr. Varnum [Member] | Year-end Fair Value of Equity Awards Granted in Covered Year that are Outstanding and Unvested |  |  |
Pay vs Performance Disclosure |  |  |
Adjustment to Compensation, Amount |  |  | 297,600
PEO | Dr. Varnum [Member] | Year-over-Year Change in Fair Value of Equity Awards Granted in Prior Years That are Outstanding and Unvested |  |  |
Pay vs Performance Disclosure |  |  |
Adjustment to Compensation, Amount |  | 5,713 | (1,194,828)
PEO | Dr. Varnum [Member] | Change in Fair Value as of Vesting Date of Prior Year Equity Awards Vested in Covered Year |  |  |
Pay vs Performance Disclosure |  |  |
Adjustment to Compensation, Amount |  | 60,616 | (185,677)
PEO | Dr. Varnum [Member] | Equity Awards Adjustments Change In Fair Value Of Awards Granted In Prior Years Forfeited During Current Year [Member] |  |  |
Pay vs Performance Disclosure |  |  |
Adjustment to Compensation, Amount |  | (121,973) |
Non-PEO NEO | Equity Awards Adjustments |  |  |
Pay vs Performance Disclosure |  |  |
Adjustment to Compensation, Amount | (143,150) | 41,094 | (307,508)
Non-PEO NEO | Aggregate Grant Date Fair Value of Equity Award Amounts Reported in Summary Compensation Table |  |  |
Pay vs Performance Disclosure |  |  |
Adjustment to Compensation, Amount | (137,225) | (33,087) | (163,386)
Non-PEO NEO | Year-end Fair Value of Equity Awards Granted in Covered Year that are Outstanding and Unvested |  |  |
Pay vs Performance Disclosure |  |  |
Adjustment to Compensation, Amount | 45,033 | 43,032 | 53,733
Non-PEO NEO | Year-over-Year Change in Fair Value of Equity Awards Granted in Prior Years That are Outstanding and Unvested |  |  |
Pay vs Performance Disclosure |  |  |
Adjustment to Compensation, Amount | (7,275) | 36,606 | (156,767)
Non-PEO NEO | Change in Fair Value as of Vesting Date of Prior Year Equity Awards Vested in Covered Year |  |  |
Pay vs Performance Disclosure |  |  |
Adjustment to Compensation, Amount | 4,366 | 10,772 | $ (41,089)
Non-PEO NEO | Equity Awards Adjustments Change In Fair Value Of Awards Granted In Prior Years Forfeited During Current Year [Member] |  |  |
Pay vs Performance Disclosure |  |  |
Adjustment to Compensation, Amount | $ (48,049) | $ (16,229) |

X
- References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-K -Number 229 -Section 402 -Subsection v -Paragraph 3 + Details
Name: | ecd_AdjToCompAmt
Namespace Prefix: | ecd_
Data Type: | xbrli:monetaryItemType
Balance Type: | na
Period Type: | duration

X
- References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-K -Number 229 -Section 402 -Subsection v -Paragraph 3 + Details
Name: | ecd_AdjToNonPeoNeoCompFnTextBlock
Namespace Prefix: | ecd_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-K -Number 229 -Section 402 -Subsection v -Paragraph 3 + Details
Name: | ecd_AdjToPeoCompFnTextBlock
Namespace Prefix: | ecd_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-K -Number 229 -Section 402 -Subsection v -Paragraph 5 -Subparagraph ii + Details
Name: | ecd_CompActuallyPaidVsNetIncomeTextBlock
Namespace Prefix: | ecd_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-K -Number 229 -Section 402 -Subsection v -Paragraph 5 -Subparagraph i + Details
Name: | ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock
Namespace Prefix: | ecd_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-K -Number 229 -Section 402 -Subsection v -Paragraph 3 + Details
Name: | ecd_NamedExecutiveOfficersFnTextBlock
Namespace Prefix: | ecd_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-K -Number 229 -Section 402 -Subsection v -Paragraph 2 -Subparagraph iii + Details
Name: | ecd_NonPeoNeoAvgCompActuallyPaidAmt
Namespace Prefix: | ecd_
Data Type: | xbrli:monetaryItemType
Balance Type: | na
Period Type: | duration

X
- References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-K -Number 229 -Section 402 -Subsection v -Paragraph 2 -Subparagraph ii + Details
Name: | ecd_NonPeoNeoAvgTotalCompAmt
Namespace Prefix: | ecd_
Data Type: | xbrli:monetaryItemType
Balance Type: | na
Period Type: | duration

X
- References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-K -Number 229 -Section 402 -Subsection v -Paragraph 2 -Subparagraph iii + Details
Name: | ecd_PeoActuallyPaidCompAmt
Namespace Prefix: | ecd_
Data Type: | xbrli:monetaryItemType
Balance Type: | na
Period Type: | duration

X
- References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-K -Number 229 -Section 402 -Subsection v -Paragraph 3 + Details
Name: | ecd_PeoName
Namespace Prefix: | ecd_
Data Type: | xbrli:normalizedStringItemType
Balance Type: | na
Period Type: | duration

X
- References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-K -Number 229 -Section 402 -Subsection v -Paragraph 2 -Subparagraph ii + Details
Name: | ecd_PeoTotalCompAmt
Namespace Prefix: | ecd_
Data Type: | xbrli:monetaryItemType
Balance Type: | na
Period Type: | duration

X
- References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-K -Number 229 -Section 402 -Subsection v -Paragraph 1 + Details
Name: | ecd_PvpTable
Namespace Prefix: | ecd_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-K -Number 229 -Section 402 -Subsection v -Paragraph 1 + Details
Name: | ecd_PvpTableTextBlock
Namespace Prefix: | ecd_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-K -Number 229 -Section 402 -Subsection v -Paragraph 2 -Subparagraph iv + Details
Name: | ecd_TotalShareholderRtnAmt
Namespace Prefix: | ecd_
Data Type: | xbrli:monetaryItemType
Balance Type: | na
Period Type: | duration

X
- Definition The portion of profit or loss for the period, net of income taxes, which is attributable to the parent. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 250 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 6 -Publisher FASB -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 250 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 9 -Publisher FASB -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Topic 805 -SubTopic 60 -Name Accounting Standards Codification -Section 65 -Paragraph 1 -Subparagraph (g) -Publisher FASB -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Topic 740 -SubTopic 323 -Name Accounting Standards Codification -Section 65 -Paragraph 2 -Subparagraph (g)(3) -Publisher FASB -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2 Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 220 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 2 -Subparagraph (SX 210.5-03(20)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2 Reference 6: http://www.xbrl.org/2003/role/disclosureRef -Topic 235 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.4-08(g)(1)(ii)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1 Reference 7: http://www.xbrl.org/2003/role/disclosureRef -Topic 323 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 3 -Subparagraph (c) -Publisher FASB -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3 Reference 8: http://www.xbrl.org/2003/role/disclosureRef -Topic 825 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 28 -Subparagraph (f) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28 Reference 9: http://www.xbrl.org/2003/role/disclosureRef -Topic 220 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 6 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482765/220-10-50-6 Reference 10: http://www.xbrl.org/2003/role/disclosureRef -Topic 250 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 3 -Publisher FASB -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3 Reference 11: http://www.xbrl.org/2003/role/disclosureRef -Topic 250 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (b)(2) -Publisher FASB -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1 Reference 12: http://www.xbrl.org/2003/role/disclosureRef -Topic 815 -SubTopic 40 -Name Accounting Standards Codification -Section 65 -Paragraph 1 -Subparagraph (f) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1 Reference 13: http://www.xbrl.org/2003/role/disclosureRef -Topic 250 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 8 -Publisher FASB -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8 Reference 14: http://www.xbrl.org/2003/role/disclosureRef -Topic 250 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 11 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11 Reference 15: http://www.xbrl.org/2003/role/disclosureRef -Topic 250 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 11 -Subparagraph (b) -Publisher FASB -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11 Reference 16: http://www.xbrl.org/2003/role/disclosureRef -Topic 250 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 4 -Publisher FASB -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4 Reference 17: http://www.xbrl.org/2003/role/exampleRef -Topic 946 -SubTopic 830 -Name Accounting Standards Codification -Section 55 -Paragraph 10 -Publisher FASB -URI https://asc.fasb.org/1943274/2147479168/946-830-55-10 Reference 18: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 220 -Name Accounting Standards Codification -Section 45 -Paragraph 7 -Publisher FASB -URI https://asc.fasb.org/1943274/2147479105/946-220-45-7 Reference 19: http://www.xbrl.org/2003/role/disclosureRef -Topic 944 -SubTopic 220 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.7-04(18)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1 Reference 20: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 220 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.6-07(9)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1 Reference 21: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 220 -Name Accounting Standards Codification -Section S99 -Paragraph 3 -Subparagraph (SX 210.6-09(1)(d)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3 Reference 22: http://www.xbrl.org/2003/role/disclosureRef -Topic 470 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1A -Subparagraph (SX 210.13-01(a)(4)(i)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A Reference 23: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 470 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1A -Subparagraph (SX 210.13-01(a)(4)(ii)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A Reference 24: http://www.xbrl.org/2003/role/disclosureRef -Topic 470 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1A -Subparagraph (SX 210.13-01(a)(4)(iii)(A)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A Reference 25: http://www.xbrl.org/2003/role/disclosureRef -Topic 470 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1A -Subparagraph (SX 210.13-01(a)(4)(iv)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A Reference 26: http://www.xbrl.org/2003/role/disclosureRef -Topic 470 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1A -Subparagraph (SX 210.13-01(a)(5)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A Reference 27: http://www.xbrl.org/2003/role/disclosureRef -Topic 470 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1B -Subparagraph (SX 210.13-02(a)(4)(i)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B Reference 28: http://www.xbrl.org/2003/role/disclosureRef -Topic 470 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1B -Subparagraph (SX 210.13-02(a)(4)(iii)(A)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B Reference 29: http://www.xbrl.org/2003/role/disclosureRef -Topic 470 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1B -Subparagraph (SX 210.13-02(a)(4)(iii)(B)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B Reference 30: http://www.xbrl.org/2003/role/disclosureRef -Topic 470 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1B -Subparagraph (SX 210.13-02(a)(4)(iv)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B Reference 31: http://www.xbrl.org/2003/role/disclosureRef -Topic 470 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1B -Subparagraph (SX 210.13-02(a)(5)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B Reference 32: http://www.xbrl.org/2003/role/disclosureRef -Topic 260 -SubTopic 10 -Name Accounting Standards Codification -Section 45 -Paragraph 60B -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B Reference 33: http://www.xbrl.org/2003/role/disclosureRef -Topic 205 -SubTopic 20 -Name Accounting Standards Codification -Section 50 -Paragraph 7 -Publisher FASB -URI https://asc.fasb.org/1943274/2147483499/205-20-50-7 Reference 34: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 230 -SubTopic 10 -Name Accounting Standards Codification -Section 45 -Paragraph 28 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28 Reference 35: http://www.xbrl.org/2003/role/disclosureRef -Topic 220 -SubTopic 10 -Name Accounting Standards Codification -Section 45 -Paragraph 1A -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1A Reference 36: http://www.xbrl.org/2003/role/disclosureRef -Topic 220 -SubTopic 10 -Name Accounting Standards Codification -Section 45 -Paragraph 1B -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1B Reference 37: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 942 -SubTopic 220 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.9-04(22)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1 + Details
Name: | us-gaap_NetIncomeLoss
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Details
Name: | ecd_IndividualAxis=armp_DrBirxMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ecd_IndividualAxis=armp_DrVarnumMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ecd_ExecutiveCategoryAxis=ecd_PeoMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ecd_AdjToCompAxis=ecd_EqtyAwrdsAdjsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ecd_AdjToCompAxis=ecd_EqtyAwrdsInSummryCompstnTblForAplblYrMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ecd_AdjToCompAxis=ecd_YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ecd_AdjToCompAxis=ecd_ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ecd_AdjToCompAxis=ecd_ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ecd_AdjToCompAxis=armp_EquityAwardsAdjustmentsChangeInFairValueOfAwardsGrantedInPriorYearsForfeitedDuringCurrentYearMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ecd_ExecutiveCategoryAxis=ecd_NonPeoNeoMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |